Vascular endothelial growth factor and angiogenin levels during fetal development and in maternal diabetes

Biology of the Neonate

Volumn 84, Issue 4, 2003, Pages 287-292

  Lassus, Patrik ^a,b   Teramo, Kari ^a   Nupponen, Irmeli ^a   Markkanen, Helene ^a   Cederqvist, Katariina ^a   Andersson, Sture ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Angiogenin; Cord blood; Diabetes; Erythropoietin; Fetal development; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIN; INSULIN; VASCULOTROPIN;

ADULT; ALLOIMMUNITY; ARTICLE; BIRTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROBLASTOSIS; EVALUATION; FEMALE; FETUS; FETUS DEVELOPMENT; GESTATIONAL AGE; HUMAN; INSULIN TREATMENT; MALE; MATERNAL DIABETES MELLITUS; MOTHER; NEWBORN; PREMATURITY; PRIORITY JOURNAL; THROMBOCYTOPENIA; UMBILICAL CORD;

DIABETES MELLITUS, TYPE 1; EMBRYONIC AND FETAL DEVELOPMENT; ERYTHROBLASTOSIS, FETAL; ERYTHROPOIETIN; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INSULIN; ISOANTIBODIES; MALE; PREGNANCY; PREGNANCY IN DIABETICS; RIBONUCLEASE, PANCREATIC; THROMBOCYTOPENIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0242353359     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073636     Document Type: Article

References (35)

1. Folkman J, Klagsburn M: Angiogenic factors. Science 1987;235:442-447.
2. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309.
3. Pepper MS, Ferrara N, Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992;89:824-831.
4. Peters KG, De Vries C, Williams L: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993;90:8915-8919.
5. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB: In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: Implications for mode of action. J Clin Endocrinol Metab 1994;79:316-322.
6. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-442.
7. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845.
8. Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF gene receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest 1995;95:1798-1807.
9. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL: Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985;24:5480-5486.
10. Strydom DJ, Fett JW, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL: Amino acid sequence of human tumor-derived angiogenin. Biochemistry 1985;24:5486-5494.
11. Shapiro R, Strydom DJ, Olson KA, Vallee BL: Isolation of angiogenin from normal human plasma. Biochemistry 1987;26:5141-5146.
12. Rybak SM, Fett JW, Yao QZ, Vallee BL: Angiogenin mRNA in human tumor and normal cells. Biochem Biophys Res Commun 1987; 146:1240-1248.
13. Shapiro R, Vallee BL: Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin: Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry 1989;28:7401-7408.
14. Shapiro R, Fox EA, Riordan JF: Role of lysines in human angiogenin: Chemical modification and site-directed mutagenesis. Biochemistry 1989;28:1726-1732.
15. Brosens I, Dixon HG, Robertson WB: Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977;84:656-663.
16. Norrby K, Jacobsson A, Simonsen M, Sörbo J: Increased angiogenesis in diabetes. Experientia 1990;46:856-860.
17. Teramo KA, Widness JA, Clemons GK, Voutilainen P, McKinlay S, Schwartz R: Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancies. Obstet Gynecol 1987;69:710-716.
18. Lassus P, Ristimäki A, Ylikorkala O, Viinikka L, Andersson S: Vascular endothelial growth factor in human preterm lung. Am J Respir Crit Care Med 1999;159:1429-1433.
19. Malamitsi-Puchner A, Tziotis J, Protonotariou E, Xyni K, Sarandakou A, Creatsas G: Heparin-binding angiogenic factors (basic fibroblast growth factor and vascular endothelial growth factor) in early neonatal life. Pediatr Res 1999;45:877-880.
20. Malamitsi-Puchner A, Sarandakou A, Giannaki G, Rizos D, Phocas I: Changes of angiogenin serum concentrations in the perinatal period. Pediatr Res 1997;41:909-911.
21. Malamitsi-Puchner A, Tziotis J, Tsonou A, Sarandakou A, Bartsocas CS, Creatsas G: Serum angiogenin levels in the female from birth to postmenopause. Growth Factors 1999;17:75-79.
22. Shapiro R, Vallee BL: Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci USA 1987;84:2238-2241.
23. Malamitsi-Puchner A, Sarandakou A, Tziotis J, Dafogianni C, Bartsocas CS: Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr Res 1998;44:873-875.
24. Singh SD: Gestational diabetes and its effect on the umbilical cord. Early Hum Dev 1986;14:89-98.
25. Malamitsi-Puchner A, Sarandakou A, Dafogianni C, Tziotis J, Bartsocas CS: Serum angiogenin levels in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Res 1998;43:798-800.
26. Dunst J, Pigorsch S, Hansgen G, Hintner I, Lautenschlager C, Becker A: Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients: Does anemia stimulate angiogenesis? Strahlenther Onkol 1999;175:93-96.
27. Martin C, Yu AY, Jiang BH, Davis L, Kimberly D, Hohimer AR, Semenza GL: Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am J Obstet Gynecol 1998;178:527-534.
28. Zetter BR: Angiogenesis: State of the art. Chest 1988;93:159-165.
29. Zanjani ED, Ascensao JL: Erythropoietin. Transfusion 1989;29:46-56.
30. Moya FR, Grannum P, Widness J, Clemons GK, Copel JA, Hobbins JC: Erythropoietin in human fetuses with immune hemolytic anemia and hydrops fetalis. Obstet Gynecol 1993;82:353-358.
31. Lemery DJ, Santolaya J, Serre AF, Denoix S, Besse GH, Vanlieferinghen PC, Bezou MJ, Gaillard G, Jackuetin B: Serum erythropoietin in small for gestational age fetuses. Biol Neonate 1994;65:89-93.
32. Mamopoulos M, Bili H, Tsantali C, Assimakopoulos E, Mantalenakis S, Farmakides G: Erythropoietin serum levels during labor in women with pre-eclampsia, diabetes, and preterm labor. Am J Perinatol 1994;11:427-429.
33. Widness JA, Teramo KA, Clemons GK, Voutilainen P, Stenman UH, McKinlay SM, Schwartz R: Direct relationship of antepartum glucose control and fetal erythropoietin in human type 1 (insulin-dependent) diabetic pregnancy. Diabetologia 1990;33:378-383.
34. Goldberg MA, Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994;269:4355-4359.
35. Sandner P, Gess B, Wolf K, Kurtz A: Divergent regulation of vascular endothelial growth factor and of erythropoietin gene expression in vivo. Pflügers Arch 1996;431:905-912.